📰 Erasca Foundation News
Erasca Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Erasca Foundation. Real-time updates on events, politics, business and more.
March 23, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2,... | March 23, 2023
March 23, 2023
Signed exclusive worldwide license for pan-RAF inhibitor naporafenib and completed concurrent $100 million equity offering Multiple clinical data readouts planned in 2023, including for HERKULES-2, HERKULES-3, FLAGSHP-1, and THUNDERBBOLT-1 trials ...